Dmitry Balyasny’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-55,717
Closed -$524K 3048
2026
Q1
$524K Buy
+55,717
New +$499K ﹤0.01% 2344
2025
Q4
Sell
-13,645
Closed -$194K 3127
2025
Q3
$194K Buy
+13,645
New +$180K ﹤0.01% 2731
2025
Q1
Sell
-30,152
Closed -$548K 2836
2024
Q4
$548K Buy
+30,152
New +$406K ﹤0.01% 2167
2024
Q1
Sell
-26,947
Closed -$610K 2655
2023
Q4
$610K Buy
+26,947
New +$584K ﹤0.01% 1867
2023
Q3
Sell
-478,620
Closed -$13.4M 2295
2023
Q2
$13.4M Buy
+478,620
New +$11.9M 0.03% 661
2023
Q1
Sell
-24,126
Closed -$641K 2694
2022
Q4
$641K Buy
24,126
+14,660
+155% +$478K ﹤0.01% 1797
2022
Q3
$269K Sell
9,466
-85,254
-90% -$2.19M ﹤0.01% 2226
2022
Q2
$1.97M Sell
94,720
-169,859
-64% -$3.18M 0.01% 1407
2022
Q1
$5.73M Sell
264,579
-99,440
-27% -$2.16M 0.02% 895
2021
Q4
$10.1M Buy
364,019
+88,040
+32% +$2.13M 0.03% 630
2021
Q3
$5.86M Buy
+275,979
New +$5.18M 0.02% 767
2020
Q2
Sell
-143,542
Closed -$967K 1157
2020
Q1
$967K Buy
+143,542
New +$1.36M 0.01% 768
2019
Q4
Sell
-83,808
Closed -$863K 1181
2019
Q3
$863K Buy
+83,808
New +$824K 0.01% 861
2017
Q4
Sell
-20,172
Closed -$287K 2074
2017
Q3
$287K Buy
+20,172
New +$253K ﹤0.01% 1553

Other funds holding CCRN

Dmitry Balyasny's CCRN Position: Q2 2026 in Review

Dmitry Balyasny sold out of Cross Country Healthcare (CCRN) in Q2 2026, closing a stake of 55,717 shares — an estimated $524K sold.

Dmitry Balyasny first reported a position in CCRN in Q3 2017 and held it in 14 quarters. The position peaked at $13.4M in Q2 2023. 148 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • Dmitry Balyasny reported no remaining Cross Country Healthcare position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 55,717 Cross Country Healthcare shares in Q2 2026, an estimated $524K.
  • Dmitry Balyasny first reported a position in Cross Country Healthcare in Q3 2017 and held it in 14 quarters.
  • Dmitry Balyasny's Cross Country Healthcare position peaked at $13.4M in Q2 2023.
  • 148 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.